THE IMMUNOLOGY OF INCREASED AGGRESSIVENESS OF SJL TUMORS
THE IMMUNOLOGY OF INCREASED AGGRESSIVENESS OF SJL TUMORS
批准号:
3176843
负责人:
STEPHEN P LERMAN
金额:
$11.29万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1984
资助国家:
美国
项目状态:
已结题
起止时间:
1984-12-01 至 1987-11-30
关键词:
T lymphocyte autologous transplantation flow cytometry gene expression genetic strain histocompatibility antigens host neoplasm interaction immunofluorescence technique leukocyte activation /transformation lymphokines lymphoma major histocompatibility complex neoplasm /cancer immunodiagnosis neoplasm /cancer immunology neoplasm /cancer invasiveness neoplasm /cancer transplantation radiotracer tumor antigens
中文摘要
点击翻译按钮获取中文摘要
英文摘要
SJL strain mice spontaneously develop lymphomas which, upon transplantation
in syngeneic mice, can grow either as indolent or aggressive tumors.
Whereas indolent tumors are at constant risk of conversion to the
aggressive type, aggressive tumors maintain their aggressiveness. The
increase in aggressiveness of SJL lymphomas correlates with absence of
H-2Ds, class I major histocompatibility complex (MHC) antigen from the
tumor cell surface. It is, herein, proposed to test the hypothesis that
the increased aggressiveness of H-2Ds negative (D-) SJL lymphomas may, in
part, be attributed to: 1) deficient killing of D-tumor cells by cytotoxic
T lymphocytes (CTL) as a consequence of preferential recognition of tumor
antigen by CTL in association with H-2Ds; 2) deficient recognition and/or
killing of D-tumor cells by natural killer cells, or; 3) a greater
sensitivity of D-tumor cells to the stimulatory influence of lymphokines
synthesized as a consequence of the T cell proliferation which accompanies
the growth of most SJL lymphomas or a greater propensity of D-lymphomas to
induce synthesis of such lymphokines. Since a similar increase in
aggressiveness is seen during the progression of some human lymphomas, it
is hoped that the results of this study will spur investigation of loss of
class I MHC antigen as a potential prognostic indicator in humans. (MI)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CORE--FLOW CYTOMETRY FACILITY
-
批准号:6101936
-
项目类别:
-
资助金额:$8.63万
-
财政年份:1999
-
负责人:STEPHEN P LERMAN
-
依托单位:
CORE--FLOW CYTOMETRY FACILITY
-
批准号:6269030
-
项目类别:
-
资助金额:$6.23万
-
财政年份:1998
-
负责人:STEPHEN P LERMAN
-
依托单位:
CORE--FLOW CYTOMETRY FACILITY
-
批准号:6236471
-
项目类别:
-
资助金额:$10.7万
-
财政年份:1997
-
负责人:STEPHEN P LERMAN
-
依托单位:
CHEMO/IMMUNOTHERAPY OF A T CELL DEPENDENT B CELL TUMOR
-
批准号:3197391
-
项目类别:
-
资助金额:$14.21万
-
财政年份:1990
-
负责人:STEPHEN P LERMAN
-
依托单位:
CHEMO/IMMUNOTHERAPY OF A T CELL DEPENDENT B CELL TUMOR
-
批准号:3197392
-
项目类别:
-
资助金额:$14.78万
-
财政年份:1990
-
负责人:STEPHEN P LERMAN
-
依托单位:
CHEMO/IMMUNOTHERAPY OF A T CELL DEPENDENT B CELL TUMOR
-
批准号:3197390
-
项目类别:
-
资助金额:$14.17万
-
财政年份:1990
-
负责人:STEPHEN P LERMAN
-
依托单位:
CORE--FLOW CYTOMETRY FACILITY
-
批准号:6441421
-
项目类别:
-
资助金额:$8.63万
-
财政年份:1988
-
负责人:STEPHEN P LERMAN
-
依托单位:
FACS 440 FLOW CYTOMETER WITH HIGH SPEED DATA NETWORK
-
批准号:3519445
-
项目类别:
-
资助金额:$30.0万
-
财政年份:1986
-
负责人:STEPHEN P LERMAN
-
依托单位:
THE IMMUNOLOGY OF INCREASED AGGRESSIVENESS OF SJL TUMORS
-
批准号:3176841
-
项目类别:
-
资助金额:$10.94万
-
财政年份:1984
-
负责人:STEPHEN P LERMAN
-
依托单位:
THE IMMUNOLOGY OF INCREASED AGGRESSIVENESS OF SJL TUMORS
-
批准号:3176844
-
项目类别:
-
资助金额:$12.36万
-
财政年份:1984
-
负责人:STEPHEN P LERMAN
-
依托单位:
海外基金